DAVID SANDERS: Open Payments
NPI 1104163856 · VINTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,746 in 95 payments from 27 companies in 2025. Trend: 2023 $2,344 · 2024 $1,946 · 2025 $1,746
Food & beverage: $1,746
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $206 |
| Otsuka America Pharmaceutical, Inc. | 11 | $202 |
| Indivior Inc. | 6 | $186 |
| Braeburn Inc. | 12 | $180 |
| Paratek Pharmaceuticals, Inc. | 12 | $163 |
| E.R. Squibb & Sons, L.L.C. | 5 | $100 |
| Novo Nordisk Inc | 5 | $93 |
| PFIZER INC. | 3 | $74 |
| Lilly USA, LLC | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
Products named: REXULTI, SUBLOCADE, BRIXADI, NUZYRA, COBENFY, BREZTRI, Wegovy, ELIQUIS.
Industry payments across VA — which companies pay providers there.
